MALANIL
LIVE

Serial Number

98960357

Owner

HAWTHORNE LIFE SCIENCES CORPORATION

Attorney

Justin Lampel

Filing Date

Jan 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MALANIL Trademark

Serial Number: 98960357

MALANIL is a trademark filed by HAWTHORNE LIFE SCIENCES CORPORATION on January 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

HAWTHORNE LIFE SCIENCES CORPORATION (3 trademarks)

100 Tower Drive Suite 238
Burr Ridge, IL 60527

Entity Type: 03

Trademark Details

Filing Date

January 14, 2025

Registration Date

Not Registered

Published for Opposition

November 4, 2025

Goods & Services

pills being pharmaceutical preparations for treatment of malaria; medicated ointment for the treatment of malaria; blister pack, namely, pharmaceutical preparations for the treatment of malaria; artemisia plant extract, other than essential oils, for treating malaria; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of malaria; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral infections; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer and bacterial infections; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cardiovascular diseases; vitamins, dietary supplements and medicinal herbal preparations for the treatment of malaria; vitamins, dietary supplements and medicinal herbal preparations for the treatment of cancer; vitamins, dietary supplements and medicinal herbal preparations for the treatment of cardiovascular disease; Topical medicated skin care preparations for the treatment of skin cancer; topical medicated skin care preparations for the treatment of acne; topical medicated skin care preparations for the treatment of alopecia; topical medicated skin care preparations for the treatment of areata; topical medicated skin care preparations for the treatment of eczema; topical medicated skin care preparations for the treatment of cellulitis being sepsis; topical medicated skin care preparations for the treatment of tinea pedis being athlete's foot; topical medicated skin care preparations of the treatment of melanoma; topical medicated skin care preparations for the treatment of sunburn; topical medicated skin care preparations for the treatment of warts and verruca; topical medicated skin care preparations for the treatment of dactylitis; topical medicated skin care preparations for the treatment of raynaud's phenomenon; topical medicated skin care preparations for the treatment of rosacea; topical medicated skin care preparations for the treatment of vitiligo; topical medicated skin care preparations for the treatment of urticaria being hives

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2025 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 1, 2025 GPRN
PRIORITY ACTION E-MAILED
Jul 1, 2025 GPRA
PRIORITY ACTION WRITTEN
Jul 1, 2025 CPRA
ASSIGNED TO EXAMINER
Jun 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2025 NWOS
NEW APPLICATION ENTERED
Jan 14, 2025 NWAP